• About Us
    • Contact Us
    • Login
    • ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
About Us Contact Us Login ObGFirst
  • COVID-19
  • Alerts
  • OB
  • 2T US Atlas
  • The Genome
  • GYN
    • 0 CME Hours
    • GYN
    • Sexual Health
  • Primary Care
  • Your Practice
  • #GrandRounds
  • My Bookshelf
  • Now@ObG
  • Media
#Grand Rounds

Are CNVs Associated with Miscarriage?

image_pdfFavoriteLoadingFavorite

BACKGROUND AND PURPOSE:

  • Chromosomal abnormalities are the most common cause of early pregnancy loss but role of submicroscopic copy-number variations (CNVs) remains unclear
  • Wang et al. (Ultrasound in Obstetrics & Gynecology, 2019) sought to identify potential miscarriage-associated submicroscopic CNVs as well as candidate genes for miscarriage

METHODS:

  • Study design
    • Over a 5-year period, fresh miscarriage specimens were analyzed using
      • Quantitative fluorescent polymerase chain reaction (qfPCR) and sequencing
      • Chromosomal microarray analysis
  • Frequency of recurrent submicroscopic CNVs were compared between miscarriage cases and a published control cohort
  • Potential candidate genes
    • Genes were prioritized based on whether miscarriage-associated CNVs disrupted critical gene regions

RESULTS:

  • 5,180 miscarriage specimens obtained | 5,003 (96.6%) did not have significant maternal-cell contamination
    • Clinically significant chromosomal abnormalities were identified in 59.1%
      • Single aneuploidies accounted for majority of these cases (43.6%) with trisomies accounting for the biggest group  
      • Partial aneuploidies (large CNVs) were noted in 3.8% of cases
      • Microdeletions and microduplications were seen in 2.7%
    • Of these abnormal cases, 97.4% could have been detected using standard G-banding cytogenetic technique (size of abnormality >10 Mb)
  • 3 recurrent submicroscopic (<10 Mb) CNVs were significantly more frequent in miscarriage cases
    • 22q11.21 | 2q37.3 | 9p24.3p24.2
  • 44 critical regions of large CNVs (14 deletions and 30 duplications) appeared to recur in the miscarriage specimens
    • Large deletions were seen most commonly in chromosomes 8, 4 and 1
    • Large duplications were seen most commonly in chromosomes 8, 7 and 11
  • Candidate genes: 309 genes were identified as possible miscarriage related genes based on gene-prioritization analysis

CONCLUSION:

  • The authors of this study identified potential genes and CNVs associated with miscarriage
  • Due to new technologies, the authors stress the importance of continuing to analyze CNVs in the study of miscarriage
  • The authors state that

22q11.21 microdeletion is a miscarriage‐causing locus, and that early embryonic death could be caused by major heart malformations resulting from the 22q11.21 deletion.

Learn More – Primary Sources:

Systematic analysis of copy‐number variations associated with early pregnancy loss

Want to be notified when new guidelines are released? Get ObGFirst!

Try it Free  »

image_pdfFavoriteLoadingFavorite
< Previous
All #Grand Rounds Posts
Next >

Related ObG Topics:

Is Prenatal Microarray Use Justified as a First Tier Test for Fetal Congenital Heart Disease?
Are Copy Number Variants Associated with Soft Markers?
Chromosomal Microarrays and Abnormal Prenatal Ultrasound Findings

Sections

  • COVID-19
  • Alerts
  • OB
  • GYN
    • GYN
    • Sexual Health
  • 2T US Atlas
  • The Genome
  • Primary Care
  • Your Practice
  • #Grand Rounds
  • My Bookshelf
  • Now@ObG
  • Media

ObG Library

  • Hysteroscopy
  • Fertility
  • Site Map/
  • © ObG Project/
  • Terms and Conditions/
  • Privacy/
  • Contact Us/
© ObG Project
SSL Certificate


  • Already an ObGFirst Member?
    Welcome back

    Log In

    Want to sign up?
    Get guideline notifications
    CME Included

    Sign Up

Get Guideline Alerts Direct to Your Phone
Try ObGFirst Free!

Sign In

Lost your password?

Sign Up for ObGFirst and Stay Ahead

  • - Professional guideline notifications
  • - Daily summary of a clinically relevant
    research paper
  • - Includes 1 hour of CME every month

ObGFirst Free Trial

Log In to ObG First

Please log in to access OBGFirst and the 2T Ultrasound Atlas

Password Trouble?

Sign Up for ObGFirst

  • - Access 2T US Atlas
  • - Guideline notifications
  • - Daily research paper summaries
  • - And lots more!

ObG First Free Trial

Media - Internet

Computer System Requirements

OBG Project CME requires a modern web browser (Internet Explorer 10+, Mozilla Firefox, Apple Safari, Google Chrome, Microsoft Edge). Certain educational activities may require additional software to view multimedia, presentation, or printable versions of their content. These activities will be marked as such and will provide links to the required software. That software may be: Adobe Flash, Apple QuickTime, Adobe Acrobat, Microsoft PowerPoint, Windows Media Player, or Real Networks Real One Player.

Disclosure of Unlabeled Use

This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. The planners of this activity do not recommend the use of any agent outside of the labeled indications.

The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of the planners. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

Disclaimer

Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information
presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient’s conditions and possible contraindications and/or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

Jointly provided by

NOT ENOUGH CME HOURS

It appears you don't have enough CME Hours to take this Post-Test. Feel free to buy additional CME hours or upgrade your current CME subscription plan

Subscribe

JOIN OBGFIRST AND GET CME/CE CREDITS

One of the benefits of an ObGFirst subscription is the ability to earn CME/CE credits from the ObG entries you read. Tap the button to learn more about ObGFirst

Learn More
Leaving ObG Website

You are now leaving the ObG website and on your way to PRIORITY at UCSF, an independent website. Therefore, we are not responsible for the content or availability of this site